Evidence map›Paper›PMID 26562835›Full record

ArticlePloS one2015

Prolonged Subdural Infusion of Kynurenic Acid Is Associated with Dose-Dependent Myelin Damage in the Rat Spinal Cord.

Wojciech Dabrowski, Jacek M Kwiecien, Radoslaw Rola, Michal Klapec, Greg J Stanisz, Edyta Kotlinska-Hasiec, Wendy Oakden, Rafal Janik, Margaret Coote, Benicio N Frey and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Kynurenic acid and cancer: facts and controversies.Cellular and molecular life sciences : CMLS · 2020
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Wojciech DabrowskiDepartment of Anaesthesiology and Intensive Therapy Medical University, Lublin, Poland.
Jacek M KwiecienDepartment of Pathology and Molecular Medicine, M. deGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
Radoslaw RolaDepartment of Neurosurgery and Paediatric Neurosurgery Medical University, Lublin, Poland.
Michal KlapecDepartment of Orthopaedic and Traumatology Medical University, Lublin, Poland.
Greg J StaniszDepartment of Medical Biophysics, University of Toronto, Ontario, Canada.
Edyta Kotlinska-HasiecDepartment of Anaesthesiology and Intensive Therapy Medical University, Lublin, Poland.
Wendy OakdenDepartment of Medical Biophysics, University of Toronto, Ontario, Canada.
Rafal JanikDepartment of Medical Biophysics, University of Toronto, Ontario, Canada.
Margaret CooteDepartment of Psychiatry and Behavioural Neurosciences, M. deGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
Benicio N FreyDepartment of Psychiatry and Behavioural Neurosciences, M. deGroote School of Medicine, McMaster University, Hamilton, Ontario, Canada.
Waldemar A TurskiDepartment of Experimental and Clinical Pharmacology, Medical University, Lublin, Poland.
Medical University of Lublin · PLMcMaster University · CAUniversity of Toronto · CASunnybrook Health Science Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKynurenic acid (KYNA) is the end stage metabolite of tryptophan produced mainly by astrocytes in the central nervous system (CNS). It has neuroprotective activities but can be elevated in the neuropsychiatric disorders. Toxic effects of KYNA in the CNS are unknown. The aim of this study was to assess the effect of the subdural KYNA infusion on the spinal cord in adult rats.

methodsA total of 42 healthy adult rats were randomly assigned into six groups and were infused for 7 days with PBS (control) or 0.0002 pmol/min, 0.01 nmol/min, 0.1 nmol/min, 1 nmol/min, and 10 nmol/min of KYNA per 7 days. The effect of KYNA on spinal cord was determined using histological and electron microscopy examination. Myelin oligodendrocyte glycoprotein (MOG) was measured in the blood serum to assess a degree of myelin damage.

resultIn all rats continuous long-lasting subdural KYNA infusion was associated with myelin damage and myelin loss that was increasingly widespread in a dose-depended fashion in peripheral, sub-pial areas. Damage to myelin sheaths was uniquely related to the separation of lamellae at the intraperiod line. The damaged myelin sheaths and areas with complete loss of myelin were associated with limited loss of scattered axons while vast majority of axons in affected areas were morphologically intact. The myelin loss-causing effect of KYNA occurred with no necrosis of oligodendrocytes, with locally severe astrogliosis and no cellular inflammatory response. Additionally, subdural KYNA infusion increased blood MOG concentration. Moreover, the rats infused with the highest doses of KYNA (1 and 10 nmol/min) demonstrated adverse neurological signs including weakness and quadriplegia.

conclusionsWe suggest, that subdural infusion of high dose of KYNA can be used as an experimental tool for the study of mechanisms of myelin damage and regeneration. On the other hand, the administration of low, physiologically relevant doses of KYNA may help to discover the role of KYNA in control of physiological myelination process.

Indexed as

AnimalsDose-Response Relationship, DrugEnzyme-Linked Immunosorbent AssayExcitatory Amino Acid AntagonistsFemaleInfusion PumpsKynurenic AcidMaleMicroscopy, Electron, TransmissionMyelin-Oligodendrocyte GlycoproteinMyelin SheathOligodendrogliaRats, Long-EvansSpinal CordSubdural SpaceTime FactorsExcitatory Amino Acid AntagonistsKynurenic AcidMyelin-Oligodendrocyte Glycoprotein

Identifiers

PMID26562835
PMCPMC4643054
OpenAlexW2414179507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.